SPL 9.20% 9.5¢ starpharma holdings limited

Ann: VIRALEZE distribution in Saudi Arabia - supplementary info, page-57

  1. 5,480 Posts.
    lightbulb Created with Sketch. 8926
    The AZN trial is definitely good news, but as with all things it moves at a snails pace... and the internal DEP phase 2 trials are surely going to deliver from a valuation perspective sooner than the AZN trials (note the current AZD0466 study isn't expected to complete until 2024, so the new one may be 2025 or 2026?).
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.